Dehydroepiandrosterone-induced polycystic ovary syndrome mouse model requires continous treatments to maintain reproductive phenotypes
Abstract Background Polycystic ovary syndrome (PCOS) is the most common endocrinopathy associated with infertility and metabolic disorder in women of reproductive age. Animal models have been developed and used as tools to unravel the pathogenesis of PCOS, among which most postnatal models employ co...
Saved in:
Main Authors: | Haowen Wu (Author), Bining Zhao (Author), Qiyang Yao (Author), Jihong Kang (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chiglitazar ameliorates dehydroepiandrosterone-induced polycystic ovary syndrome in rats
by: Fuzhen Zhao, et al.
Published: (2024) -
The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats
by: Gengxiang Wu, et al.
Published: (2020) -
Short‐term rapamycin administration elevated testosterone levels and exacerbated reproductive disorder in dehydroepiandrosterone‐induced polycystic ovary syndrome mice
by: Zaixin Guo, et al.
Published: (2021) -
THE OVARIAN RESERVE FOR WOMEN OF REPRODUCTIVE RETURN WITH POLYCYSTIC OVARY SYNDROME IN DEPENDENCE ON THE PHENOTYPE
by: Светлана Ивановна Елгина, et al.
Published: (2018) -
The use of dehydroepiandrosterone-treated rats is not a good animal model for the study of metabolic abnormalities in polycystic ovary syndrome
by: Kok-Min Seow, et al.
Published: (2018)